202 related articles for article (PubMed ID: 36828916)
1. BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer.
Sun G; Wei Y; Zhou B; Wang M; Luan R; Bai Y; Li H; Wang S; Zheng D; Wang C; Wang S; Zeng K; Liu S; Lin L; He M; Zhang Q; Zhao Y
Cell Death Differ; 2023 May; 30(5):1260-1278. PubMed ID: 36828916
[TBL] [Abstract][Full Text] [Related]
2. An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer.
Sun G; Wang C; Wang S; Sun H; Zeng K; Zou R; Lin L; Liu W; Sun N; Song H; Liu W; Zhou T; Jin F; Shan Z; Zhao Y
Nucleic Acids Res; 2020 Nov; 48(19):10768-10784. PubMed ID: 32986841
[TBL] [Abstract][Full Text] [Related]
3. A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation.
Korkmaz G; Manber Z; Lopes R; Prekovic S; Schuurman K; Kim Y; Teunissen H; Flach K; Wit E; Galli GG; Zwart W; Elkon R; Agami R
Nucleic Acids Res; 2019 Oct; 47(18):9557-9572. PubMed ID: 31372638
[TBL] [Abstract][Full Text] [Related]
4. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
5. CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions.
Fiorito E; Sharma Y; Gilfillan S; Wang S; Singh SK; Satheesh SV; Katika MR; Urbanucci A; Thiede B; Mills IG; Hurtado A
Nucleic Acids Res; 2016 Dec; 44(22):10588-10602. PubMed ID: 27638884
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional co-activator NCOA6 promotes estrogen-induced GREB1 transcription by recruiting ERα and enhancing enhancer-promoter interactions.
Tong Z; Liu Y; Yu X; Martinez JD; Xu J
J Biol Chem; 2019 Dec; 294(51):19667-19682. PubMed ID: 31744881
[TBL] [Abstract][Full Text] [Related]
7. Cooperativity of co-factor NR2F2 with Pioneer Factors GATA3, FOXA1 in promoting ERα function.
Jiang G; Wang X; Sheng D; Zhou L; Liu Y; Xu C; Liu S; Zhang J
Theranostics; 2019; 9(22):6501-6516. PubMed ID: 31588232
[TBL] [Abstract][Full Text] [Related]
8. Luminal lncRNAs Regulation by ERα-Controlled Enhancers in a Ligand-Independent Manner in Breast Cancer Cells.
Miano V; Ferrero G; Rosti V; Manitta E; Elhasnaoui J; Basile G; De Bortoli M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29462945
[TBL] [Abstract][Full Text] [Related]
9. SRC-3 Coactivator Governs Dynamic Estrogen-Induced Chromatin Looping Interactions during Transcription.
Panigrahi AK; Foulds CE; Lanz RB; Hamilton RA; Yi P; Lonard DM; Tsai MJ; Tsai SY; O'Malley BW
Mol Cell; 2018 May; 70(4):679-694.e7. PubMed ID: 29775582
[TBL] [Abstract][Full Text] [Related]
10. A Non-canonical Role of YAP/TEAD Is Required for Activation of Estrogen-Regulated Enhancers in Breast Cancer.
Zhu C; Li L; Zhang Z; Bi M; Wang H; Su W; Hernandez K; Liu P; Chen J; Chen M; Huang TH; Chen L; Liu Z
Mol Cell; 2019 Aug; 75(4):791-806.e8. PubMed ID: 31303470
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional genome architectural CCCTC-binding factor makes choice in duplicated enhancers at Pcdhα locus.
Wu Y; Jia Z; Ge X; Wu Q
Sci China Life Sci; 2020 Jun; 63(6):835-844. PubMed ID: 32249388
[TBL] [Abstract][Full Text] [Related]
12. Distinct Roles for BET Family Members in Estrogen Receptor α Enhancer Function and Gene Regulation in Breast Cancer Cells.
Murakami S; Li R; Nagari A; Chae M; Camacho CV; Kraus WL
Mol Cancer Res; 2019 Dec; 17(12):2356-2368. PubMed ID: 31551256
[TBL] [Abstract][Full Text] [Related]
13. Heat shock factor 1 (HSF1) cooperates with estrogen receptor α (ERα) in the regulation of estrogen action in breast cancer cells.
Vydra N; Janus P; Kus P; Stokowy T; Mrowiec K; Toma-Jonik A; Krzywon A; Cortez AJ; Wojtas B; Gielniewski B; Jaksik R; Kimmel M; Widlak W
Elife; 2021 Nov; 10():. PubMed ID: 34783649
[TBL] [Abstract][Full Text] [Related]
14. The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin.
Guo C; Meza-Sosa KF; Valle-Garcia D; Zhao G; Gao K; Yu L; Zhang H; Chen Y; Sun L; Rockowitz S; Wang S; Jiang S; Lieberman J
Proc Natl Acad Sci U S A; 2023 Feb; 120(8):e2206878120. PubMed ID: 36791099
[TBL] [Abstract][Full Text] [Related]
15. Dynamic assembly and activation of estrogen receptor α enhancers through coregulator switching.
Murakami S; Nagari A; Kraus WL
Genes Dev; 2017 Aug; 31(15):1535-1548. PubMed ID: 28887413
[TBL] [Abstract][Full Text] [Related]
16. The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells.
Stender JD; Stossi F; Funk CC; Charn TH; Barnett DH; Katzenellenbogen BS
Mol Endocrinol; 2011 Oct; 25(10):1699-709. PubMed ID: 21868451
[TBL] [Abstract][Full Text] [Related]
17. Estrogen induces dynamic ERα and RING1B recruitment to control gene and enhancer activities in luminal breast cancer.
Zhang Y; Chan HL; Garcia-Martinez L; Karl DL; Weich N; Slingerland JM; Verdun RE; Morey L
Sci Adv; 2020 Jun; 6(23):eaaz7249. PubMed ID: 32548262
[TBL] [Abstract][Full Text] [Related]
18. Nonlinear relationship between chromatin accessibility and estradiol-regulated gene expression.
Chen D; Parker TM; Bhat-Nakshatri P; Chu X; Liu Y; Wang Y; Nakshatri H
Oncogene; 2021 Feb; 40(7):1332-1346. PubMed ID: 33420376
[TBL] [Abstract][Full Text] [Related]
19. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells.
Hao L; Rizzo P; Osipo C; Pannuti A; Wyatt D; Cheung LW; Sonenshein G; Osborne BA; Miele L
Oncogene; 2010 Jan; 29(2):201-13. PubMed ID: 19838210
[TBL] [Abstract][Full Text] [Related]
20. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
